Plasma Proteomics Study of End-Stage Liver Disease Patients Based on Olink Technology
NCT06865898 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 58
Last updated 2025-03-10
Summary
Exploring Early Biomarkers of Hepatitis B Virus-Related Acute-on-Chronic Liver Failure Using Olink Proteomics
Conditions
- HBV Related Acute-on-chronic Liver Failure
Sponsors & Collaborators
-
Qilu Hospital of Shandong University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-03-01
- Primary Completion
- 2025-03-31
- Completion
- 2025-03-31
Countries
- China
Study Locations
More Related Trials
-
Safety and Efficacy of Human Autologous Peripheral Blood Stem Cells for Treatment of HBV-related Liver Cirrhosis
NCT01728688 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
the Role of plin5 in the Development of Nonalcoholic Fatty Liver Disease.
NCT04104282 ·Status: RECRUITING
-
Clinical Trial of Umbilical Cord Mesenchymal Stem Cell Transfusion in Decompensated Liver Cirrhosis
NCT03529136 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of BMS-986171 in Healthy People to Assess Safety, to Measure Blood Levels of Drug, and to Find Out What the Drug Does to the Body
NCT02538874 ·Status: COMPLETED ·Phase: PHASE1
-
Allogenic Bone Marrow Mesenchymal Stem Cell Therapy in Acute-on-chronic Liver Failure
NCT02857010 ·Status: TERMINATED ·Phase: PHASE1
-
ALT-801 in Diabetic and Non-Diabetic Overweight and Obese Subjects With Non-alcoholic Fatty Liver Disease (NAFLD)
NCT05006885 ·Status: COMPLETED ·Phase: PHASE1
-
RL-1 Novel Human-derived Bio-artificial Liver Treatment in Patients of HBV Related ACLF
NCT04195282 ·Status: UNKNOWN ·Phase: NA
-
Human Menstrual Blood-derived Mesenchymal Stem Cells for Patients With Liver Cirrhosis
NCT01483248 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Moexipril for Primary Biliary Cirrhosis
NCT00588302 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Tolerability Study of OP-724 in Liver Cirrhosis Patients by HIV/HCV with Hemophilia.
NCT04688034 ·Status: COMPLETED ·Phase: PHASE1
-
The Safety ,Tolerability and Efficacy Study of HepaCure in Chinese Subjects with Acute-On-Chronic Liver Failure
NCT05989958 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Mesenchymal Stem Cell Transplantation for Acute-on-chronic Liver Failure
NCT03668171 ·Status: UNKNOWN ·Phase: NA
-
Diagnostic and Therapeutic Applications of Microarrays in Liver Transplantation
NCT03193151 ·Status: RECRUITING
-
Performance of Scoring Systems in Chinese Patients With Primary Biliary Cholangitis (PBC) on Ursodeoxycholic Acid
NCT03188146 ·Status: COMPLETED
-
REpurposing SirolimUS in Compensated Advanced Chronic Liver Disease. the RESUS Proof of Concept Study
NCT05663944 ·Status: COMPLETED ·Phase: PHASE2
-
The Ameliorative Effect of C-Kit (+) Hepatic Endothelial Cells With Mertk Deficiency on Nonalcoholic Steatohepatitis
NCT06913699 ·Status: ACTIVE_NOT_RECRUITING
-
Umbilical Cord Mesenchymal Stem Cells Transplantation Combined With Plasma Exchange for Patients With Liver Failure
NCT01724398 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Chinese Phase II Trail of AS1501 in Acute-on-chronic Liver Failure (ACLF) Patients
NCT06916585 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Study in Reversing Hepatic Fibrosis or Cirrhosis Related to Hepatitis B Virus and Finding Biomarkers
NCT03568578 ·Status: UNKNOWN ·Phase: NA
-
Cardiox Liver Function Test Pivotal Trial
NCT02552901 ·Status: WITHDRAWN ·Phase: PHASE3
-
A Hepatitis B With Hepatic Steatosis Study
NCT02392598 ·Status: UNKNOWN
-
A Study of Experimental Medication BMS-986036 Given to Healthy Participants
NCT03445208 ·Status: COMPLETED ·Phase: PHASE1
-
Umbilical Cord Mesenchymal Stem Cells for Patients With Liver Cirrhosis
NCT01220492 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Remedial Mechanism of Simvastatin and Ursodeoxycholic Acid in Liver Cirrhosis: Crosstalk of Bile Secretion, Gut Microbiome, and Host Immune Response
NCT07102979 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Study of [14C]CS0159 in China Healthy Subjects
NCT06098027 ·Status: COMPLETED ·Phase: PHASE1